271 related articles for article (PubMed ID: 11249957)
1. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.
Marcus MM; Mathé JM; Nomikos GG; Svensson TH
Neuropharmacology; 2001 Mar; 40(4):482-90. PubMed ID: 11249957
[TBL] [Abstract][Full Text] [Related]
2. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
3. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
Dall'olio R; Rimondini R; Gandolfi O
Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
[TBL] [Abstract][Full Text] [Related]
4. Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens.
Reijmers LG; Vanderheyden PM; Peeters BW
Eur J Pharmacol; 1995 Jan; 272(2-3):131-8. PubMed ID: 7713156
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
Kretschmer BD
J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
[TBL] [Abstract][Full Text] [Related]
7. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
8. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
Ouagazzal A; Amalric M
Eur J Pharmacol; 1995 Dec; 294(1):137-46. PubMed ID: 8788425
[TBL] [Abstract][Full Text] [Related]
9. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
Bubser M; Keseberg U; Notz PK; Schmidt WJ
Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
[TBL] [Abstract][Full Text] [Related]
10. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
11. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens.
Kosowski AR; Liljequist S
J Pharmacol Exp Ther; 2004 Nov; 311(2):560-7. PubMed ID: 15256539
[TBL] [Abstract][Full Text] [Related]
12. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats.
Hyytiä P; Bäckström P; Liljequist S
Eur J Pharmacol; 1999 Jul; 378(1):9-16. PubMed ID: 10478559
[TBL] [Abstract][Full Text] [Related]
13. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.
Kantak KM; Edwards MA; O'Connor TP
Pharmacol Biochem Behav; 1998 Jan; 59(1):159-69. PubMed ID: 9443551
[TBL] [Abstract][Full Text] [Related]
15. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.
Löscher W; Annies R; Hönack D
Eur J Pharmacol; 1993 Oct; 242(3):263-74. PubMed ID: 7904243
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
Kuroki T; Tatebayashi Y; Ide K; Yonezawa Y; Tsutsumi T; Matsumoto T; Hirano M; Uchimura H
Neuropeptides; 1992 Mar; 21(3):167-73. PubMed ID: 1385857
[TBL] [Abstract][Full Text] [Related]
17. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
18. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
Hussain N; Flumerfelt BA; Rajakumar N
Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
[TBL] [Abstract][Full Text] [Related]
19. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.
Pierce RC; Meil WM; Kalivas PW
Psychopharmacology (Berl); 1997 Sep; 133(2):188-95. PubMed ID: 9342786
[TBL] [Abstract][Full Text] [Related]
20. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
Tan SE
Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]